Infectious Disease
RSSArticles
-
An Effective Oral Regimen for Rifampin-Resistant Tuberculosis
A multicenter, randomized, controlled, noninferiority clinical trial found a 24-week, all-oral regimen (bedaquiline, pretomanid, linezolid, and moxifloxacin) to be safe and effective for patients aged 15 years and older with rifampin-resistant tuberculosis.
-
COVID Is Not ‘Just the Flu’
Among hospitalized patients requiring oxygen support at admission, COVID-19 was three times more fatal than was influenza.
-
Inching Toward the Goal: Does Selective Decontamination of the Digestive Tract Have a Benefit for Patients on Mechanical Ventilation?
Two recent articles contribute to the ongoing discussion of whether selective decontamination of the digestive tract provides a mortality benefit for patients who are receiving mechanical ventilation.
-
Medical Masks Compared to N95 Respirators for COVID-19 Prevention in Healthcare Workers
A multicenter, randomized, controlled study found that medical masks were noninferior to N95 respirators in their relative protection against COVID-19 among healthcare workers when worn while providing routine care to patients with suspected or confirmed COVID-19.
-
Infectious Disease Alert Updates
Is Your Hospital Room Toxigenic?; Reduction of HOCDI — Gaming the System?
-
Physician Autonomy at Issue if Patients Demand Ineffective Treatments
A controversial Wisconsin Supreme Court case centers on whether physicians can be legally required to provide ivermectin for COVID-19 if a patient or family requests it.
-
Tocilizumab Injection (Actemra)
The FDA has approved tocilizumab injection to treat COVID-19 among hospitalized adult patients who are receiving systemic corticosteroids and require supplemental oxygen.
-
COVID-19: Beware Remdesivir Resistance
Researchers reported two immunosuppressed renal transplant recipients with persistent SARS-CoV-2 infection in association with the new emergence of mutations in RNA-dependent RNA polymerase after remdesivir treatment.
-
Fecal Microbiota, live-jslm (Rebyota)
Rebyota can be prescribed to prevent recurring Clostridioides difficile infection for patients age 18 years and older who are following antibiotic treatment for recurring episodes.
-
Statin Use with Daptomycin: Do We Finally Have a Definitive Answer?
A meta-analysis on published literature and a disproportionality analysis using Food and Drug Administration data found that statin use was associated with the occurrence of daptomycin-induced musculoskeletal adverse events. In most cases, statin use should be discontinued while patients are on daptomycin.